Given the number of comorbidities associated with obesity, the market's growth will impact the entire cardiometabolic disease ...

The international consulting firm Clarivate makes its bet among the novelties ready for the medicine cabinet this year: three ...

Court rulings against parts of Donald Trump's agenda put White House officials on the defensive. Hamas says it will not ...

Operator Ladies and gentlemen, thank you for standing by and welcome to the Lilly Q4 2024 earnings call. [Operator ...

If approved for the new indication, it could add a major new growth driver for semaglutide, which is already seeing sales rocket on the back of its use as Ozempic ... buyouts in Japan's health ...

Rybelsus (semaglutide) is the first GLP-1 agonist drug that can be dosed orally, and is Novo Nordisk's third drug in the class after daily injectable Victoza (liraglutide) and weekly shot Ozempic ...

There's growing evidence to suggest that GLP-1 drugs, which include semaglutide, may be useful for treating alcohol use disorder.

The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those with T2D and CKD.

Some people who use semaglutide (Ozempic, others) have noted sagging skin in the buttocks, calling it “Ozempic butt.” While lifestyle modifications may help prevent this weight loss side ...

The FDA has approved popular antiobesity drug Ozempic to help protect patients with type 2 diabetes from kidney disease.

Hey Dada,” my six-year-old says. “When did Japan start believing in Pokemon?” It’s day three of our journey through the land of the rising sun and we’re getting to the big questions.

R.Park, A.R.Allen, C.B.Brown, R.Chahayed, O.Fedi, P.M.Lawrence II, Bruno Mars, T.M.Thomas, H.R.Walter, M.D.Chapman, N.Chinn Bruno Mars, Cirkut, O.Fedi, R.Chahayed ...